跳至主要内容
临床试验/NCT06493968
NCT06493968招募中不适用

Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With Placenta Accrete Spectrum Disorders Undergoing Cesarean Hysterectomy

Cairo University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
70
试验地点
1
主要终点
Intraoperative blood loss

研究概览

简要总结

Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnancy of singleton living fetus
  • Previous one or more cesarean sections
  • Gestational age: > 32 weeks
  • The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder wall", "utero-vesicalhypervascularity".
  • Preoperative hemoglobin more than 10 gm/dl
  • Cases with PAS that will undergoing CS Hysterectomy

排除标准

  • Maternal medical disorders e.g.: coagulation defects, cardiac diseases etc.....
  • Any known or reported hypersensitivity to the used medication.
  • All cases with spontaneous placental separation at laparotomy.
  • All patients undergoing conservative management of PAS.
  • All cases which necessitate emergency termination.

研究组 & 干预措施

Group (A)

Experimental

Patients will be given uterotonics

干预措施: oxytocin (Drug)

Group (B)

Placebo Comparator

Patients will not be given uterotonics

干预措施: placebo (Other)

结局指标

主要结局

Intraoperative blood loss

时间窗: during operation

amount of intraoperative blood loss in patients with PAS disorders undergoing cesarean hysterectomy

次要结局

  • operative time(during operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdalla Mousa

Lecturer of obgyn Cairo university

Cairo University

研究点 (1)

Loading locations...

相似试验

Role of Uterotonics in Reducing Intraoperative Blood... | 临床试验